The new potential tracer of bone imaging, AHBDP-Sn(II)-TcO.3H20 was synthesized by reducing the TcO4" to TcO 2+ in the presence of AHBDP and Sn(ll)'s reducing agent. We found that tin rapidly forms a stable complex with AHBDP, giving AHBDP-Sn(II).3H20. In the excess of AHBDPSn(ll).3H20, the AHBDP-Sn(II).3H20 coordinates with TcO 2+ to give AHBDP-Sn(II)-TcO.3H20 which could polymerise or oligomerise to give hydrophobic species. The overall process appears as a first-order reaction (k= 0.67 +_. 0.005 s'l). In rats, the fixation of AHBDP-Sn(II)-99mTcO. 3H20 on bone is homogeneous and the scintigraphic images have the same quality as those of 1-hydroxymethane-l,l-diphosphonate-Technetium (HMDp-99mTc). The activity in non-target organs was neglible.
INTRODUCTION
4-amino-l-hydroxybutane-l,l-diphosphonate (AHBDP) is a diphosphonate derivative. Diphosphonate-technetium complexes such as 1-hydroxymethane-l,l-diphosphonatetechnetium (HMDP-Tc), 1-hydroxyethane-l,l-diphosphonate (HEDP-Tc) (Chart 1), etc. are widely used in bone scintigraphy. It is well-known that these complexes can exist as monomers, polymers or oligomers, and also that in technetium, in different oxidation states, frequently as +4 and +5 as well as +3 and +6, different valence states may exist together, depending on the experimental conditions 1-4.
The subsequent reduction of TcO4(') from +7 to a lower level of oxidation in the presence of various ligands is essential for radiopharmaceuticals. Stannous chloride (SnCI2) is frequently used as a reducing agent for TcO4('). Unfortunately, in aqueous solution, Sn(ll) is easily hydrolyzed and.
oxidized. Its solution is stable only in the presence of hydrochloric acid 5-9. However, it has been reported that a large excess of SnCI 2 in labelling systems affects not only the quality, purity and stability of the radiopharmaceuticals, but also the biological behaviour of 99mTc-complexes.
Sn(ll) forms chelates with many substrates so that the labelling procedures generally yield a mixture of tin and technetium chelates [10] [11] [12] Deutsch proposed that tin can and does bind to T complexes 1.
Vol. 2, No. 4, 1995 Synthesis of 4-Amino-l-Hydroxy-Butane-l,l-Diphosphonate Huigen et al. showed that the HEDP-Sn(II)-Tc has a molecular charge between -4 and -9 at pH 7 and that in an acidic pH, the charge increases 13 .Tji et al showed that the diphosphonatetechnetium complexes adsorb on calcium phosphate, as a model of bone adsorption. For the -Tc(lll), -Tc(IV), and HEDP-Tc(V) complexes, the adsorption on calcium phosphate increases in the following order Tc(V) < Tc(IV) < Tc(lll) 3. It was observed that the chemical structure of complexes affects the biological behavior. According to its In order to identify the products of the reaction, two series of experiments were carried out in the following conditions" [AHBDP] [Sn(ll)] =10 -2 M. In the first series the pH was equal to 2, while in the second, it was adjusted to 11 with NaOH. After the completion of the reaction, the solutions were lyophilized and the products were analyzed by 31p.NMR. It should be noted that the lyophilized powder at pH 11 was instable in the ambient conditions; its color changed from white to black and became insoluble in water. On the other hand, the lyophilized powder at pH 2 [NaOH], M We have verified that AHBDP-Sn(II) solutions were stable for several hours and we always used fresh solutions in our experiments.
Spectmphotometric studies
In this series of experiments, the concentration of AHBDP-Sn(II) varie from 10 "6 to 2 x 10 -3 M and the concentration of TcO 4(') varied from 10 -6 to 10 "2 M. The pH varied from 1.5 to 11.
Immediately after the mixture of AHBDP-Sn(II) and TcO 4(') the solution became yellow. For the following series of solutions with equimolar amounts of AHBDP-Sn(II) and TcO4(') and the excess of the TcO 4('), the solutions became opaque and were composed of a brown precipitate.
For the excess solutions of AHBDP-Sn(II), [AHBDP-Sn(II)] 10[TCO4(')], the evolution of the absorption spectra was investigated. The absorbance at 224 nm immediately increased after the addition of TcO4(') and then decreased before stabilising. There was a new absorption band at 400 nm. The evolutions of the absorbance at 400 nm are reported in figure 2 . A pseudo plateau was reached by absorbance, within 25 minutes; however, the absorption spectra changed slowly and a yellow precipitate appeared over 72 hours. It should be noted that the pseudo plateau was attained independently of the initial concentrations of the reagent, as it can be seen in the inset of Figure 2 . In these conditions of stoichiometry 1:1 the composition of the solution at the pseudo plateau was thus independent of the reagent concentrations and the average extinction for the complexes could be calculated using the slope of the straight line of inset of Figure 2 2190 M"l.cm "1 All curves, such as the one in figure 2 , could be analysed according to a firstorder kinetic law, with a rate constant of 0.67 + 0.005 s "1 We have verified that the formation of the complex was independent of pH and that complex was stable as a function of dilution.
Potentiometric titrations of AHBDP-Sn(II)-Tc
The titration curves are illustrated in figure 3 for AHBDP-Sn(II) chelates Tc for 1:0, 1:10 and 1:25 ratios of metal to ligand. In steep inflection, the three curves were identical, there were no protons released from the complex for pH < 6. It is possible that after the reduction of the TcO4(') to TcO(2+), the AHBDP-Sn(II) chelates TcO (2+) forming a complex as shown in scheme 2. The . . could either polymerise or oligomerise to give the formation of the hydrophobic species, indicated by the yellow precipitate in the solution after 72 hours.
Biodistribution of AHBDP-Sn(II)-99mTc in rat 3.1 Preparation of the AHBDP-Sn(II)-99mTc
Paper chromatography of AHBDP-Sn(II)-99mTc (prepared under the conditions described above) showed that all the activity was Iocalised at the origin. These results showed that the AHBDP-Sn(II)-99mTc was almost free from Na99mTco4 The yield of labelling was about 96 % and the complexes was stable for at least two hours.
Tissue distribution
Uptake of the AHBDP in various organs of rats at 0.5,1, 2 and 3 hours post injection, indicated that the greater part of the complex was distributed in the rats' bones, kidneys and urinary bladders. Lungs, spleen, liver, heart and muscle showed negligible activity. Per gram organ uptake, as shown in table 1, was found to be highest in bone as compared to the other organs.
Studies on blood clearance of the AHBDP showed that during the initial post injection period, there was a rapid loss of activity in the blood and it was reduced to only 6% of the injection dose Vol. 2, No. 4, 1995 Synthesis of 4-Amino-l-Hydroxy-Butane-l,l-Diphosphonate within 30 minutes. Thereafter, further clearance was lower at hour post injection, the blood still showed 2% of the injected activity. 
